# Tulex Pharmaceuticals Inc. – FDA Inspection, Mar 24, 2025

Source: https://www.keypedia.com/records/fda_inspections/tulex-pharmaceuticals-inc/3085aa66-b7a0-4815-9e58-5d1875897b55
Source feed: FDA_Inspections

> FDA inspection 1264812 of Tulex Pharmaceuticals Inc., March 24, 2025. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 211. Form 483 issued. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1264812
- Company Name: Tulex Pharmaceuticals Inc.
- Inspection Date: 2025-03-24
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: New Jersey District Office
- Citation Count: 2

## Related Documents

- FDA Inspection 1256966 - 2024-12-05
- FDA Inspection 1232755 - 2024-02-29
- FDA Inspection 1129002 - 2020-08-14
- FDA Inspection 1053140 - 2018-04-05
- [FDA Inspection 1031819 - 2017-11-21](https://www.keypedia.com/records/fda_inspections/tulex-pharmaceuticals-inc/a0867f8e-3b5f-4fc5-ad03-788d5b196185)

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/james-r-birkenstamm/eb1192a4-3c76-4243-886c-9b5805871ad1)
- [Investigator](https://www.keypedia.com/people/suchan-kim/1acf9a36-036f-48a8-a8a4-caa290830e37)

Company: https://www.keypedia.com/companies/tulex-pharmaceuticals-inc/e9839d9b-b973-49c3-916a-4ca187d606dd

Office: https://www.keypedia.com/offices/new-jersey-district-office/6ff5e2e9-5cff-44c7-af24-5a55329a8248
